A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Bob Belderbos; P Baas; R Berardi; Robin Cornelissen; DA Fennell; JP van Meerbeeck; A Scherpereel; Heleen Vroman; Joachim Aerts; Koen Bezemer; A Rafaelian; M Poncin; I Goktas; Eric Braakman; L van Hove; J Klok; AN Geel; M Vries; Cecile Janssens; X (Xiaoxue) Zhang; J Raskin; S Kohl; A Hufkens; R Claes; MC Willemin; E Wasielewski; M Grammont; S Batista; M Pinturaud; Z Ballatore; A Lucarelli; M Burattini; C Tonnini; F Bianchi; S Pagliaretta; M Hudka; K Lord; L Darlison; B Varadhan; A Hunter

doi:10.21037/tlcr.2019.05.05

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Bob Belderbos, P Baas, R Berardi, Robin Cornelissen, DA Fennell, JP van Meerbeeck, A Scherpereel, Heleen Vroman, Joachim Aerts, Koen Bezemer, A Rafaelian, M Poncin, I Goktas, Eric Braakman, L van Hove, J Klok, AN Geel, M Vries, Cecile Janssens, X (Xiaoxue) ZhangJ Raskin, S Kohl, A Hufkens, R Claes, MC Willemin, E Wasielewski, M Grammont, S Batista, M Pinturaud, Z Ballatore, A Lucarelli, M Burattini, C Tonnini, F Bianchi, S Pagliaretta, M Hudka, K Lord, L Darlison, B Varadhan, A Hunter

Research output: Contribution to journal › Article › Academic › peer-review

52 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	280-285
Number of pages	6
Journal	Translational Lung Cancer Research
Volume	8
Issue number	3
DOIs	https://doi.org/10.21037/tlcr.2019.05.05
Publication status	Published - 2019

Research programs

EMC MM-02-41-04
EMC MM-03-47-11

Access to Document

10.21037/tlcr.2019.05.05

http://hdl.handle.net/1765/117899

Cite this

Belderbos, B., Baas, P., Berardi, R., Cornelissen, R., Fennell, DA., van Meerbeeck, JP., Scherpereel, A., Vroman, H., Aerts, J., Bezemer, K., Rafaelian, A., Poncin, M., Goktas, I., Braakman, E., van Hove, L., Klok, J., Geel, AN., Vries, M., Janssens, C., ... Hunter, A. (2019). A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial. Translational Lung Cancer Research, 8(3), 280-285. https://doi.org/10.21037/tlcr.2019.05.05

Belderbos, Bob ; Baas, P ; Berardi, R et al. / A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial. In: Translational Lung Cancer Research. 2019 ; Vol. 8, No. 3. pp. 280-285.

@article{92c9035c7f5f4bd08b089c55c30bf6b1,

title = "A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial",

author = "Bob Belderbos and P Baas and R Berardi and Robin Cornelissen and DA Fennell and \{van Meerbeeck\}, JP and A Scherpereel and Heleen Vroman and Joachim Aerts and Koen Bezemer and A Rafaelian and M Poncin and I Goktas and Eric Braakman and \{van Hove\}, L and J Klok and AN Geel and M Vries and Cecile Janssens and Zhang, \{X (Xiaoxue)\} and J Raskin and S Kohl and A Hufkens and R Claes and MC Willemin and E Wasielewski and M Grammont and S Batista and M Pinturaud and Z Ballatore and A Lucarelli and M Burattini and C Tonnini and F Bianchi and S Pagliaretta and M Hudka and K Lord and L Darlison and B Varadhan and A Hunter",

year = "2019",

doi = "10.21037/tlcr.2019.05.05",

language = "Undefined/Unknown",

volume = "8",

pages = "280--285",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

publisher = "Society for Translational Medicine (STM)",

number = "3",

}

Belderbos, B, Baas, P, Berardi, R, Cornelissen, R, Fennell, DA, van Meerbeeck, JP, Scherpereel, A, Vroman, H, Aerts, J , Bezemer, K, Rafaelian, A, Poncin, M, Goktas, I, Braakman, E, van Hove, L, Klok, J, Geel, AN, Vries, M, Janssens, C, Zhang, X, Raskin, J, Kohl, S, Hufkens, A, Claes, R, Willemin, MC, Wasielewski, E, Grammont, M, Batista, S, Pinturaud, M, Ballatore, Z, Lucarelli, A, Burattini, M, Tonnini, C, Bianchi, F, Pagliaretta, S, Hudka, M, Lord, K, Darlison, L, Varadhan, B & Hunter, A 2019, 'A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial', Translational Lung Cancer Research, vol. 8, no. 3, pp. 280-285. https://doi.org/10.21037/tlcr.2019.05.05

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial. / Belderbos, Bob; Baas, P; Berardi, R et al.
In: Translational Lung Cancer Research, Vol. 8, No. 3, 2019, p. 280-285.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

AU - Belderbos, Bob

AU - Baas, P

AU - Berardi, R

AU - Cornelissen, Robin

AU - Fennell, DA

AU - van Meerbeeck, JP

AU - Scherpereel, A

AU - Vroman, Heleen

AU - Aerts, Joachim

AU - Bezemer, Koen

AU - Rafaelian, A

AU - Poncin, M

AU - Goktas, I

AU - Braakman, Eric

AU - van Hove, L

AU - Klok, J

AU - Geel, AN

AU - Vries, M

AU - Janssens, Cecile

AU - Zhang, X (Xiaoxue)

AU - Raskin, J

AU - Kohl, S

AU - Hufkens, A

AU - Claes, R

AU - Willemin, MC

AU - Wasielewski, E

AU - Grammont, M

AU - Batista, S

AU - Pinturaud, M

AU - Ballatore, Z

AU - Lucarelli, A

AU - Burattini, M

AU - Tonnini, C

AU - Bianchi, F

AU - Pagliaretta, S

AU - Hudka, M

AU - Lord, K

AU - Darlison, L

AU - Varadhan, B

AU - Hunter, A

PY - 2019

Y1 - 2019

U2 - 10.21037/tlcr.2019.05.05

DO - 10.21037/tlcr.2019.05.05

M3 - Article

C2 - 31367541

SN - 2218-6751

VL - 8

SP - 280

EP - 285

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

IS - 3

ER -

Belderbos B, Baas P, Berardi R, Cornelissen R, Fennell DA, van Meerbeeck JP et al. A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial. Translational Lung Cancer Research. 2019;8(3):280-285. doi: 10.21037/tlcr.2019.05.05